Celaid Therapeutics

Developer of cell therapies for the treatment of blood cancer

placeBunkyo, Tokyo, Japan calendar_todayFounded 2020 groups8 employees language celaidtx.com

Social engagement

Social engagement: 556 social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital360%
Other / undisclosed240%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

20 Oct 2025 · Clinical Science Lead / Program Lead

Based on job postings tracked across public sources.

Recent activity

11 Jun 2026
Event
BIO International Convention 2026
3 Jun 2026
Event
European Hematology Association (EHA) 2026 Congress
15 Apr 2026
Event
HExaT Meeting 2026
Coming soon